GlaxoSmithKline Plc's experimental AIDS drug reduced the virus as much as 500-fold without the signs of resistance linked to treatments from Merck & Co. and Gilead Sciences Inc., a study showed.
Glaxo AIDS Drug Has 'Spectacular' Results in StudyCourtesy Newsvine - business Wed, 07/22/2009 - 07:14
GlaxoSmithKline Plc's experimental AIDS drug reduced the virus as much as 500-fold without the signs of resistance linked to treatments from Merck & Co. and Gilead Sciences Inc., a study showed. Related itemsNotable 52-Week Highs and Lows of the Day 02/06:...
Notable 52-Week Highs and Lows of the Day 02/03:...
Notable 52-Week Highs and Lows of the Day 01/10:...
Samsung SCX-4200 3-in-1 True Multifunction Printer
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
|
Popular by tags WeekMonth |
Post new comment